ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Concepts Approved For $26.5Million In DCPC contracts, Including Heavy Smoker Program

February 1, 1985

Health Organizations Endorse “Patients’ Rights” Document

November 17, 1995

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

Litton’s New Fredrick Award Could Total Around $30 Million

July 30, 1976

Study: Freezing Secondary Tumors Helpful in Metastatic Breast Cancer

March 30, 2012